* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Drug concentration
Survey
Document related concepts
Neuropharmacology wikipedia , lookup
Drug discovery wikipedia , lookup
Pharmacognosy wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Psychopharmacology wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Discovery and development of integrase inhibitors wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Discovery and development of HIV-protease inhibitors wikipedia , lookup
Prescription costs wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Drug interaction wikipedia , lookup
Discovery and development of non-nucleoside reverse-transcriptase inhibitors wikipedia , lookup
Transcript
HIV i-Base • STEP • EATG HIV Training for Advocates Section 3: Introduction to ARV Therapy HIV i-Base: Training for Advocates, 10/2004 www.i-Base.info Combination therapy • HIV is continually reproducing - an it uses CD4 cells as factories to produce more virus. • The drugs work at different parts of the HIV lifecycle • Available drugs work in one of four ways: i) reverse transcriptase inhibitors (RTIs, nukes) ii) NNRTIs - non-nukes iii) protease inhibitors (PIs) iv) entry inhibitors (T-20) HIV i-Base: Training for Advocates, 10/2004 www.i-Base.info HIV lifecycle H IV virus entry inhi bitors C D4 cell nukes & non-nukes (N NRTIs) HIV i-Base: Training for Advocates, 10/2004 protease i nhibi tor s www.i-Base.info HIV uses CD4 cells as factories to make hundreds of copies of itself. Different drugs work at different stages of the HIV lif Choice of drugs 1. There are now approx 20 approved anti-HIV drugs and more in development (see page 16 of the i-Base guide) 2. Some are more potent than others 3. A few cannot be used together (ie d4T and AZT) 4. Recent studies and guidelines recommend using two RTIs and either one NNRTI or one PI-based combination as being most effective: i) AZT / 3TC / efavirenz ii) AZT / 3TC / lopinavir/r (Kaletra) 5. BUT many other combinations are better for some people: - every drug has different advantages and disadvantages, and newer drugs are being used as first line therapy HIV i-Base: Training for Advocates, 10/2004 www.i-Base.info How to get treatment right • HIV treatment is different to other medications • Weak treatment (less than 3 drugs) or missing doses (even one dose a week) will lead to resistance, and the combination will fail • Once resistance develops it never reverses • Resistance will make the next combination less likely to succeed - because there is cross-resistance between most drugs in each class HIV i-Base: Training for Advocates, 10/2004 www.i-Base.info Resistance • When HIV reproduces - it makes mistakes - so new virus is not exactly the same • Most of these changes do not matter, but some will stop HIV drugs from working • Resistance only develops when you are taking treatment with a detectable viral load • Main cause of resistance is poor adherence HIV i-Base: Training for Advocates, 10/2004 www.i-Base.info Adherence • A ‘little’ HIV treatment is very dangerous • Treatment needs to be ‘all or nothing’ • Missing doses (even one dose a week) can lead to resistance if you do this regularly • This is because you need to keep levels of each drug in your combination above a minimum level • Once you start treatment, getting a strategy to never miss a dose is the most important thing you have to do in your life. Especially critical for first months. HIV i-Base: Training for Advocates, 10/2004 www.i-Base.info Drug absorption After taking a drug, levels peak quickly and then slowly drop as the drug is eliminated - every drug has its own drug absorption curves C Max Drug concentration AUC = Area Under Curve 0 T Max dos e HIV i-Base: Training for Advocates, 10/2004 Time T 1/2 www.i-Base.info Drug absorption.2 Each dose taken on time makes sure that you keep above a mimimum level C Max Drug concent ration C Min or C tough 0 Time dose dose HIV i-Base: Training for Advocates, 10/2004 dose www.i-Base.info Drug levels and resistance.1 Taking drugs at the exact time makes sure that you keep above a mimimum level Increased risk of side effects Drug concentration MEC (Minimum Effective Concentration) Increased risk of resistance 0 dose HIV i-Base: Training for Advocates, 10/2004 dose dose dose www.i-Base.info Drug levels and resistance.2 Accuracy of your dosing will keep you out of the risk zone for resistance Increased risk of side effects Drug concentration MEC (Minimum Effective Concentration) Increased risk of resistance 0 dose dose HIV i-Base: Training for Advocates, 10/2004 Missed dose Late dose dose www.i-Base.info Side Effects • Be an active patient • Nearly always a choice in every situation - combination therapy is not ‘fixed’ but very flexible • Effective treatment includes Quality of Life • Research alternatives • Follow research for new information (ie lipodystophy) HIV i-Base: Training for Advocates, 10/2004 www.i-Base.info Future development Focus of huge quantity of research: - New drugs - New targets - New strategies - treatment interruptions - boosted-PI monotherapy - boosting immune responses - individualising treatment (IQ etc) HIV i-Base: Training for Advocates, 10/2004 www.i-Base.info